What Is Tesamorelin? FDA-Approved Use, Side Effects and Monitoring
Learn what tesamorelin is approved to treat, why its role differs from weight-loss drugs, and what patients should know about risks and monitoring.
By Moukhtar Itani
Published
Updated

Tesamorelin is a prescription peptide that stimulates the release of growth hormone. FDA-approved tesamorelin products are indicated to reduce excess abdominal fat in adults with HIV and lipodystrophy. The prescribing information describes a weight-neutral effect. The indication applies to specific approved products and a defined patient population. EGRIFTA WR prescribing information · MedlinePlus
What is HIV-associated lipodystrophy?
Lipodystrophy refers to changes in where the body stores fat. In this setting, a person with HIV may have excess fat deep in the abdomen. Prescribing studies focused on abdominal visceral fat in people with HIV-associated lipodystrophy. That measurement can change even when the number on the scale stays about the same. A clinician assesses whether the fat distribution fits the approved indication and how it relates to the person’s overall health. EGRIFTA WR prescribing information
What does monitoring involve?
Tesamorelin can raise insulin-like growth factor 1, known as IGF-1, and affect blood glucose. The approved label calls for glucose assessment before treatment and monitoring during treatment, along with IGF-1 monitoring. It lists active malignancy, pregnancy, certain disruptions of the pituitary axis, and known hypersensitivity among the contraindications. Long-term cardiovascular safety remains unestablished in the approved prescribing information. EGRIFTA WR prescribing information
Frequently asked questions
Is tesamorelin FDA-approved for weight loss?
The approved indication is excess abdominal fat in adults with HIV-associated lipodystrophy. The label specifies that the product has a weight-neutral effect and excludes weight management from its indications. EGRIFTA WR prescribing information
Is tesamorelin a GLP-1 drug?
Tesamorelin is a growth hormone–releasing factor analog. It acts through the pituitary growth hormone pathway. That mechanism differs from that of GLP-1 drugs. EGRIFTA WR prescribing information
Is tesamorelin the same as sermorelin?
They are distinct compounds that act on the growth hormone pathway. Use the prescribing information for the exact product to check its approved indication, contraindications, and monitoring requirements. EGRIFTA WR prescribing information · FaroRx sermorelin guide
What side effects can tesamorelin cause?
The approved label lists reactions including injection-site redness or itching, joint pain, muscle pain, and swelling. It also describes risks such as hypersensitivity and increases in blood sugar. Ask your prescriber which symptoms should prompt a call and which require urgent care. EGRIFTA WR prescribing information · MedlinePlus
Can tesamorelin affect blood sugar?
Yes. Tesamorelin can lead to new or worsening glucose intolerance. The approved labeling recommends checking blood sugar before starting and monitoring it during treatment. EGRIFTA WR prescribing information
Is compounded tesamorelin the same as EGRIFTA?
EGRIFTA is an FDA-approved product. Compounded drugs have their own formulation and do not undergo FDA premarket review. The evidence and instructions for one approved formulation apply to that product. FDA compounding FAQ · EGRIFTA WR prescribing information
Is tesamorelin with ipamorelin FDA-approved?
The EGRIFTA approval covers tesamorelin in the labeled product and population. It does not extend to a tesamorelin–ipamorelin combination. Compounded combinations lack FDA approval. EGRIFTA WR prescribing information · FDA compounding FAQ
Related reading
FaroRx sermorelin guide · FaroRx quality and safety information
This article is for general education only and is not medical advice. Compounded medications are not FDA-approved and are not generic versions of, or equivalent to, any branded medication. Prescribed only when clinically appropriate after an online medical visit.
Ready to see if you qualify?
Take a short online visit and a licensed provider will review your intake.
See if you qualify
